Semnur touts Phase I/II trial of non-opioid pain-killer

Semnur Pharmaceuticals touted data today from a Phase I/II pharmacokinetic trial of its injectable, non-opioid pain-killer, SP-102. The trial enrolled 12 patients with radicular pain.

The trial met its primary endpoint and showed that single epidural injection of SP-102 could provide a sustained analgesic effect for 1 month.

Get the full story at our sister site, Drug Delivery Business News.

The post Semnur touts Phase I/II trial of non-opioid pain-killer appeared first on MassDevice.

from MassDevice http://ift.tt/2rTVd60